VEGF-A and FGF-2 are predominantly angiogenic markers where VEGF-A is significantly involved in calcific of aortic valve disease [8], while FGF-2 is involved in AS through increased matrix remodeling, proliferation, and inhibition of profibrotic markers [10]. The gene discussed is FGF2; the disease is aortic valve disorder.